Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Debt to Equity (2020 - 2026)

Bioventus filings provide 6 years of Debt to Equity readings, the most recent being $1.52 for Q4 2025.

  • On a quarterly basis, Debt to Equity fell 33.21% to $1.52 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.52, a 33.21% decrease, with the full-year FY2025 number at $1.52, down 33.21% from a year prior.
  • Debt to Equity hit $1.52 in Q4 2025 for Bioventus, down from $1.94 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $2.27 in Q4 2024 to a low of $0.59 in Q4 2021.
  • Median Debt to Equity over the past 5 years was $1.66 (2023), compared with a mean of $1.41.
  • Biggest five-year swings in Debt to Equity: plummeted 54.95% in 2021 and later soared 198.86% in 2023.
  • Bioventus' Debt to Equity stood at $0.59 in 2021, then soared by 72.3% to $1.01 in 2022, then surged by 63.65% to $1.66 in 2023, then skyrocketed by 36.69% to $2.27 in 2024, then tumbled by 33.21% to $1.52 in 2025.
  • The last three reported values for Debt to Equity were $1.52 (Q4 2025), $1.94 (Q3 2025), and $1.7 (Q2 2025) per Business Quant data.